racemetirosine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 2 studies
alpha-Methyltyrosine: An inhibitor of the enzyme TYROSINE 3-MONOOXYGENASE, and consequently of the synthesis of catecholamines. It is used to control the symptoms of excessive sympathetic stimulation in patients with PHEOCHROMOCYTOMA. (Martindale, The Extra Pharmacopoeia, 30th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "He had a negative evaluation for malignant hyperthermia (MH), and we suggest that NMS differs from MH." | 1.26 | Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease. ( Burke, RE; Fahn, S; Louis, K; Mayeux, R; Weinberg, H; Willner, JH, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ortiz, AN | 1 |
| Kurth, BJ | 1 |
| Osterhaus, GL | 1 |
| Johnson, MA | 1 |
| Burke, RE | 1 |
| Fahn, S | 1 |
| Mayeux, R | 1 |
| Weinberg, H | 1 |
| Louis, K | 1 |
| Willner, JH | 1 |
2 other studies available for racemetirosine and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Dysregulation of intracellular dopamine stores revealed in the R6/2 mouse striatum.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; alpha-Methyltyrosine; Animals; Biophysics; | 2010 |
Neuroleptic malignant syndrome caused by dopamine-depleting drugs in a patient with Huntington disease.
Topics: Adolescent; Adult; alpha-Methyltyrosine; Antipsychotic Agents; Child; Dopamine; Dystonia; Female; Fe | 1981 |